The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies

H. Mou, V. Stalin Raj, F.J.M. van Kuppeveld, P.J.M. Rottier, B.L. Haagmans, B.J. Bosch

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The spike (S) protein of the recently emerged human Middle East respiratory syndrome coronavirus (MERS-CoV) mediates infection
by binding to the cellular receptor dipeptidyl peptidase 4 (DPP4). Here we mapped the receptor binding domain in the S
protein to a 231-amino-acid fragment (residues 358 to 588) by evaluating the interaction of spike truncation variants with receptor-
expressing cells and soluble DPP4. Antibodies to this domain—much less so those to the preceding N-terminal region—efficiently
neutralize MERS-CoV infection.
Original languageEnglish
Pages (from-to)9379-9383
Number of pages5
JournalJournal of Virology
Volume87
Issue number16
DOIs
Publication statusPublished - 2013

Keywords

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Binding Sites
  • Cell Line
  • Coronavirus
  • Dipeptidyl Peptidase 4
  • Epitopes, B-Lymphocyte
  • Humans
  • Membrane Glycoproteins
  • Receptors, Virus
  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • Virus Attachment

Fingerprint

Dive into the research topics of 'The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies'. Together they form a unique fingerprint.

Cite this